Page last updated: 2024-08-21

triphenyltetrazolium and zd 9379

triphenyltetrazolium has been researched along with zd 9379 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, M; Meiler, MR; Takano, K; Tatlisumak, T	1

Other Studies

1 other study(ies) available for triphenyltetrazolium and zd 9379

Article	Year
A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Stroke, 1998, Volume: 29, Issue:1 Topics: Analysis of Variance; Animals; Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Infarction; Coloring Agents; Cortical Spreading Depression; Electroencephalography; Glycine; Infusions, Intravenous; Injections, Intravenous; Ischemic Attack, Transient; Linear Models; Male; N-Methylaspartate; Neuroprotective Agents; Placebos; Pyridazines; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Tetrazolium Salts	1998

Article

Year

A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.

Stroke, 1998, Volume: 29, Issue:1

Topics: Analysis of Variance; Animals; Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Infarction; Coloring Agents; Cortical Spreading Depression; Electroencephalography; Glycine; Infusions, Intravenous; Injections, Intravenous; Ischemic Attack, Transient; Linear Models; Male; N-Methylaspartate; Neuroprotective Agents; Placebos; Pyridazines; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Tetrazolium Salts

1998